Business ❯Healthcare ❯Pharmaceuticals

Oncology

Cisplatin-Induced Ototoxicity Sales Performance Gastrointestinal Cancers Guardant Health Collaboration Drug Development Clinical Trials Cancer Immunotherapy

FTSE 100 Companies Deliver Record Profits but Flag Trade Risks

Record margins are tempered by warnings of tariff costs, with the challenge of sustaining licensing windfalls

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

Johnson & Johnson Raises Revenue Forecast Despite Legal Costs Impact